bpc-157 evidence human trials safety Just Cleared a Major Regulatory Hurdle If you've been following the peptide world, you've probably heard the buzz about BPC-157. Here's what actually happened: ✓ An FDA advisory committee voted to FDA's Review Of Peptides Signals

BPC-157's unusual gastric stability stems from its origin as a fragment of a naturally occurring gastric protective protein

Autonomic dysregulation, reflecting the disruption of neurotransmitter homeostasis and most frequently manifesting as temperature instability, was documented primarily in SRD and AR-GTPCHD (almost 35%)

Administration of a medication forces a physiological reaction, even if that medication is body-identical, a new buzz term in the healthcare sector

In April 2025, the Journal of Pharmacology and Experimental Therapeutics retracted the 2014 paper that established dihexa's proposed mechanism the idea that it works through hepatocyte growth factor and the c-Met system to build synapses